RING THERAPEUTICS
Swiss trademark · 799306 · Word mark · In force
Register entry
- Registration number
- 799306
- Application number
- 07691/2023
- Status
- In force
- Type
- Word mark
- Filed
- Apr 22, 2019
- Registered
- Jun 23, 2023
- Published
- Jun 23, 2023
- Protected until
- Apr 22, 2029
- Priority
- 25.10.2018 US
- Remarks
- Umwandlung der internationalen Registrierung Nr. 1471506 (Art. 46a MschG).
- Language of procedure
- French
- Source
- Swissreg
Goods and services
Pharmaceuticals
Acides nucléiques encapsulés utilisés comme biothérapies dans la thérapie génique pour le traitement de troubles génétiques rares, maladies cardiovasculaires, maladies respiratoires, maladies infectieuses, maladies de la rétine, troubles métaboliques, troubles hormonaux, maladies endocriniennes, maladies et troubles oculaires, maladies gastro-intestinales, maladies auto-inflammatoires et auto-immunes, maladies inflammatoires, maladies musculo-squelettiques, troubles neurologiques, affections hématologiques, affections cutanées, maladies neurodégénératives, troubles congénitaux, maladies rénales et urinaires, maladies de la reproduction, maladies mitochondriales, affections pulmonaires, maladies du système immunitaire, maladies de la bouche, maladies digestives.
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Dec 21, 2023
Holder’s address changed
- Owner
- RING THERAPEUTICS, INC, 55 CAMBRIDGE PARKWAY, SUITE 800E, CAMBRIDGE MA 02142 (US), USA → RING THERAPEUTICS, INC, 140 First Street, Cambridge, MA 02141, USA
Published in Swissreg on 21.12.2023
- Jun 23, 2023
Registered
Published in Swissreg on 23.06.2023
Parties
The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.